Hypothesis / aims of study
Female stress urinary incontinence (SUI) is a highly prevalent disease . It has a significant negative impact on quality of life and the wellbeing of female patients. Single-incision slings (SIS) have been developed to reduce patient pain and discomfort by avoiding the trajectory through the adductor muscles while keeping outcomes similar to those with a standard midurethral sling. The Altis is a new, tension-adjustable, SIS procedure for the treatment of SUI. There are limited studies on its treatment outcomes but few studies have shown good cure rate [2-3]. This study aims to describe our initial experience with the Altis Single Incision Sling (SIS) for the treatment of female Stress Urinary Incontinence (SUI), including its efficacy and safety, at one month follow up.
Study design, materials and methods
In this retrospective, single center study, we included 65 patents with a history of pure SUI or mixed urinary incontinence with predominantly SUI symptoms who had a positive cough stress test or urodynamic diagnosis of SUI. All patients underwent Altis Single Incision Sling between August 2017 and Oct 2018 by a single surgeon at our center. Patient characteristics such as age, races, parity, BMI, menopausal status were recorded. Patients were reviewed at 1 month post-surgery. The pre-operative parameters, intra-operative details, immediate post-operative and one month follow-up data of these patients were evaluated. Primary outcome measured includes the objective and subject cure rates, confirmed by negative stress test and patient’s reported improvement of SUI symptoms respectively post procedure. Complications studied includes intra-operative complications e.g. bladder perforation, bleeding requiring transfusion, post-operative complications e.g. pain, tape erosion, voiding disorders, infection etc.
Interpretation of results
The short term cure rates and perioperative complications for Altis SIS were comparable to other studies on mid-urethral sling surgery. It appears to be safe and effective. However, longer term follow up data to further evaluate outcome and complications is required and is being collected.